About Ranbaxy Laboratories Ltd
Data last updated:
Ranbaxy Laboratories Ltd was a public limited company based in Mohali, Punjab, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 June 1961.
The company was registered with the Registrar of Companies (ROC), Chandigarh, under CIN L24231PB1961PLC003747. It is recorded as listed by MCA, but its shares were delisted from BSE on 02 Sep 2015 · merger, and no longer trade on a stock exchange.
The company had an authorised share capital of ₹300 Cr and a paid-up capital of ₹212.83 Cr. It was led by directors including Arun Sawhney (Managing Director) and Rajesh Viren Shah.
Its last annual general meeting (AGM) was held on 28 July 2014, and its latest financial statements are for the year ended 31 March 2014. The registered office was at A – 41 Industrial Area Phase VIII – A, Mohali, Punjab, India – 160071.
As per the financials filed for FY 2014, the company reported a revenue of ₹1.35 Lakh, a growth of 5% compared to the previous year.
The company was associated with 1 brand: Ranbaxy Laboratories. As per MCA filings, the company had satisfied charges of ₹23.05 Cr on record. Court records list 632 cases involving the company, including 358 filed by the company and 274 filed against it; 58 cases are pending. The company has 5 deals on record (4 acquisitions, 1 market trade); the latest was in March 2015. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Allegro Remedies Private Limited with revenue of ₹1.41 Lakh.
The last known website on record is ranbaxy.com.
Company details
CIN history
Ranbaxy Laboratories has one previous CIN (Corporate Identification Number): U24231PB1961PLC003747. The current CIN is L24231PB1961PLC003747, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24231PB1961PLC003747 | Current |
| U24231PB1961PLC003747 | Previous |
Contact details
Ranbaxy Laboratories Ltd's registered office is in Mohali, Punjab.
- Registered AddressA – 41 Industrial Area Phase VIII – A, Mohali, Punjab, India – 160071
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Ranbaxy Laboratories operates one associated brand: Ranbaxy Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| A well-diversified pharma company manufacturing & marketing range of pharmaceutical products | ranbaxy.com |
Financials of Ranbaxy Laboratories Ltd
FY 2014 filings availableRanbaxy Laboratories Ltd reported revenue of ₹1.35 Lakh (up 5% YoY) for FY 2014.
Compounded Annual Growth Rate (CAGR)
Revenue rose 5% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2013-14 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2013-14 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Ranbaxy Laboratories Ltd, buy the company report.
Board of directors and KMP of Ranbaxy Laboratories Ltd
Ranbaxy Laboratories Ltd currently reports 8 directors and 1 key managerial person. 18 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Viren Shah | Director | 29 May 2009 | 17 Years 5 Months | As last reported |
| Akihiro Watanabe | Director | 09 May 2011 | 15 Years 5 Months | As last reported |
| Arun Sawhney Also directs: Granules India Limited | Managing Director | 09 May 2011 | 15 Years 5 Months | As last reported |
| Percy Keku Shroff | Director | 27 Mar 2009 | 17 Years 7 Months | As last reported |
| Takashi Shoda | Director | 19 Dec 2008 | 17 Years 10 Months | As last reported |
| Tsutomu Une | Director | 10 May 2010 | 16 Years 5 Months | As last reported |
Peer comparison
Ranbaxy Laboratories Ltd is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Allegro Remedies Private Limited | ₹1.41 Lakh (FY 2025) | -73.0% | Delhi, India | |||
| Clini Vigil Pharma Solutions Private Limited | ₹1.39 Lakh (FY 2021) | Hyderabad, Telangana, India | ||||
| Zed Life Sciences Private Limited | ₹1.38 Lakh (FY 2020) | Ahmedabad, Gujarat, India | ||||
| Innocure Pharma Private Limited | ₹1.35 Lakh (FY 2025) | 62.0% | Tiruvannamalai, Tamil Nadu, India | |||
| Gayatri Pharmaceuticals Pvt Ltd | ₹1.35 Lakh (FY 2025) | -24.0% | Cuttack, Odisha, India | |||
| Ranbaxy Laboratories Ltdthis company | ₹1.35 Lakh (FY 2014) | 5.0% | Mohali, Punjab, India | |||
| Athachi Wellness Solutions Private Limited | ₹1.34 Lakh (FY 2025) | 173.0% | Palakkad, Kerala, India | |||
| Harwell Lifesciences Private Limited | ₹1.33 Lakh (FY 2021) | -80.0% | Bangalore, Karnataka, India | |||
| Silva Pharmaceuticals Private Limited | ₹1.3 Lakh (FY 2025) | 0.0% | Kolkata, West Bengal, India | |||
| Globax Healthcare Private Limited | ₹1.3 Lakh (FY 2024) | -66.0% | Noida, Uttar Pradesh, India | |||
| Bonsai Pharmachem Limited | ₹1.3 Lakh (FY 2025) | -1.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Ranbaxy Laboratories Ltd, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Jul 1994 | 80050808 | Bank of America | ₹23.05 Cr | Satisfied |
To see the full charge records of Ranbaxy Laboratories Ltd, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Ranbaxy Laboratories Ltd has 5 deals on record (4 acquisitions, 1 market trade); the latest was in March 2015.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2015 | Acquisition | Undisclosed | Buyer: Emcure Pharmaceuticals Limited Seller: Ranbaxy Laboratories Ltd |
| Apr 2014 | Acquisition | ₹24,128 Cr | Buyer: Sun Pharmaceutical Industries Limited Seller: Daiichi Sankyo Company |
| Dec 2009 | Acquisition | ₹63.97 Cr | Buyer: HNG Chembio Pharmacy Co. Ltd. Seller: Ranbaxy Laboratories Ltd |
| Jun 2008 | Acquisition | ₹17,456 Cr | Buyer: Daiichi Sankyo Company Ltd. |
| Mar 2006 | Market trade | ₹330.68 Cr | Buyer: Ubs Securities Asia Ltd. Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Ranbaxy Laboratories Ltd has 632 court cases on record: 358 filed by Ranbaxy Laboratories, 274 filed against it. 58 cases are pending and 574 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 414 | 156 | 49 |
| District courts | 178 | 95 | 8 |
| Supreme Court | 40 | 23 | 1 |
Cases on record (5 of 632)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (4302-Service Laws : Promotion, seniority, payment of salary, bonus, provident fund, service benefits, equal pay for equal work, pay scales, transfer) | Filed by the company against an individual | Pending |
| High Court of Delhi | Court case (C.O. (COMM.IPD-TM)) | Filed against the company by Medley Pharmaceuticals Ltd | Pending |
| High Court of Delhi | Commercial suit | Filed by the company against M/S Intas Pharmaceuticals Ltd & Ors. | Pending |
| High Court, CHANDIGARH (UT) | Court case (OLR) | Filed by the company against M/S Haryana Drugs and Pharmaceuticals Limited | Disposed |
| District court, Vadodara, Gujarat | Civil suit | Filed by the company against Gama Exports Pvt. Ltd. and 1 other | Disposed |
To see the full case history of Ranbaxy Laboratories Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ranbaxy Laboratories Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Ranbaxy Laboratories Ltd; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Ranbaxy Laboratories Ltd has 43 board changes on record since 1992: 26 appointments and 17 cessations. The latest: Kazunori Hirokawa was appointed as Director on 09 May 2012.
37 earlier events are in the company report.
News
From our blog
- Top 5 Pharma Companies in India-202126 Feb 2021
Frequently asked questions
Ranbaxy Laboratories has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Ranbaxy Laboratories was a public limited company based in Mohali, Punjab, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 16 June 1961 and is registered under CIN L24231PB1961PLC003747. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Ranbaxy Laboratories was incorporated on 16 June 1961. It is registered with the Registrar of Companies, Chandigarh.
Ranbaxy Laboratories had 9 directors and KMP:
- Arun Sawhney - Managing Director
- Rajesh Viren Shah - Director
- Akihiro Watanabe - Director
- Percy Keku Shroff - Director
- Takashi Shoda - Director
- Tsutomu Une - Director
- Anthony Hugh Wild - Director
- Kazunori Hirokawa - Director
- Sushil Kumar Patawari - Company Secretary
The CIN (Corporate Identification Number) of Ranbaxy Laboratories is L24231PB1961PLC003747. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ranbaxy Laboratories is recorded as a listed company by MCA, but its shares were delisted from BSE on 02 Sep 2015 · merger, and no longer trade on a stock exchange.
The registered office of Ranbaxy Laboratories is at A – 41 Industrial Area Phase VIII – A, Mohali, Punjab, India – 160071.
Ranbaxy Laboratories can be reached through the website ranbaxy.com. Its registered office is in Mohali, Punjab, India.
The latest financial statements of Ranbaxy Laboratories on record with the MCA are for the year ended 31 March 2014. Its last annual general meeting was held on 28 July 2014. Year-wise statements from 2015 are in the company report.
Ranbaxy Laboratories operated in the pharma industry, in the drug formulation and development segment.
Ranbaxy Laboratories has 5 deals on record (4 acquisitions, 1 market trade); the latest was in March 2015.